News | September 28, 2021
Bal Pharma ramps up API capacity of Gliclazide
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
The company is the Clinical Research Organisation of Caplin Point Laboratories
Cephalosporin is a bactericidal, broad-spectrum, and P-lactam antibiotic originally derived from the fungus Acremonium, which is used to treat bacterial infections such as pneumonia, skin infections, ear infection, strep throat, staph infections, tonsillitis, bronchitis among others
The order strengthens the company’s position in the East African market
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
The approval allows it to market its products in the country
A new market study published by Global Industry Analysts (GIA), released its report titled, ``Healthcare Supply Chain Management—Global Market Trajectory & Analytics.’’ We present excerpts from the report
The transaction is expected to close in the Q4FY22
Robust demand for the product across the Middle East, Africa and Latin America
Drug formulations and biologics make impressive gains
Subscribe To Our Newsletter & Stay Updated
